Corbion: Q1 2023 Interim Management Statement
Corbion: Q1 2023 Interim Management Statement
"In a high inflationary environment, we delivered strong growth in Q1 in both Net sales and Adjusted EBITDA. We successfully secured price increases in the course of 2022 as compensation for higher input costs. We are now starting to see some relaxation in input prices.Corbion, the Amsterdam-listed sustainable ingredients company that champions preservation through the application of science, today publishes its results for the quarter ending 31 March 2023.
在阿姆斯特丹上市的可持续配料公司Corbion倡导通过应用科学进行保护，今天公布了截至2023年3月31日的季度业绩。
Key highlights first quarter of 2023
202年第一季度的主要亮点3.
- Net sales € 359.6 million; an increase of 12.3%, of which organic 8.9%
- Adjusted EBITDA € 48.4 million; an increase of 21.0%, of which organic 18.5%
- Operating profit € 26.9 million; a decline of 10.9% due to last year's book profit of € 9.0 million related to the sale of a US warehouse. Organic growth of 16.5%.
- Core Net sales: organic growth 9.9%, higher prices more than offset a decline in volume/mix
- Core Adjusted EBITDA: organic growth 18.5%
- FY23 outlook improved: core Adjusted EBITDA organic growth at high end of range 15-20%
- 'Advance 2025' strategy implementation on-track
- 净销售额3.596亿欧元，增长12.3%，其中有机8.9%
- 调整后的EBITDA为4840万欧元；增长21.0%，其中有机增长18.5%
- 营业利润2,690万欧元；下降10.9%，原因是去年与出售美国仓库有关的账面利润为900万欧元。有机增长16.5%。
- 核心净销售额：有机增长9.9%，更高的价格抵消了销量/组合的下降
- 调整后的核心EBITDA：有机增长18.5%
- 23财年前景改善：核心调整后的EBITDA有机增长在15%-20%的高端
- 《先行2025》战略实施步入正轨
| € million | Q1 2023 | Q1 2022 | Total growth | Organic growth |
| Net sales | 359.6 | 320.1 | 12.3% | 8.9% |
| Adjusted EBITDA | 48.4 | 40.0 | 21.0% | 18.5% |
| Operating profit | 26.9 | 30.2 | -10.9% | 16.5% |
| Core activities | ||||
| Net sales | 312.5 | 276.2 | 13.1% | 9.9% |
| Adjusted EBITDA | 41.6 | 34.7 | 19.9% | 18.5% |
| 百万欧元 | 2023年第一季度 | 2022年第一季度 | 总增长 | 有机增长 |
| 净销售额 | 359.6 | 320.1 | 12.3% | 8.9% |
| 调整后的EBITDA | 48.4 | 40.0 | 21.0% | 18.5% |
| 营业利润 | 26.9 | 30.2 | -10.9% | 16.5% |
| 核心活动 | ||||
| 净销售额 | 312.5 | 276.2 | 13.1% | 9.9% |
| 调整后的EBITDA | 41.6 | 34.7 | 19.9% | 18.5% |
Commenting on today's results, Olivier Rigaud, CEO, said:
在评论今天的业绩时，首席执行官奥利维尔·里戈德表示：
"In a high inflationary environment, we delivered strong growth in Q1 in both Net sales and Adjusted EBITDA. We successfully secured price increases in the course of 2022 as compensation for higher input costs. We are now starting to see some relaxation in input prices.
“在高通胀环境下，我们在第一季度实现了净销售额和调整后EBITDA的强劲增长。我们成功地在2022年实现了价格上涨，作为对更高投入成本的补偿。我们现在开始看到投入价格有所放缓。”
In Sustainable Food Solutions, we have experienced destocking in the value chain, as well as some indications of softening of consumer demand in line with macro conditions. As previously indicated, we expect our expansion plans in product/market adjacencies to contribute to sales growth in the second half of 2023. In Lactic Acid & Specialties, we have seen a continuation of lower levels of sales to the TotalEnergies Corbion joint venture, whilst our Pharma and Biomedical businesses continue to perform well. The Algae Ingredients business has maintained strong and profitable growth, and we have initiated activities to generate additional growth beyond aquaculture.
在可持续食品解决方案中，我们经历了价值链的去库存，以及一些迹象表明，消费者需求在宏观条件下出现疲软。如前所述，我们预计我们在产品/市场邻近地区的扩张计划将有助于2023年下半年的销售增长。在乳酸和特种产品方面，我们看到TotalEnergy Corbion合资企业的销售额继续下降，而我们的医药和生物医学业务继续表现良好。藻类配料业务一直保持强劲和盈利的增长，我们已经启动了一些活动，以创造水产养殖以外的额外增长。
Building on Corbion's first-quarter performance and despite some challenging circumstances, we are on-track to improve our absolute adjusted EBITDA for the full year, and have accordingly raised our expected growth to the upper end of our 15-20% guidance range. Furthermore, the divestment process of our US emulsifiers business is progressing well, and we anticipate to conclude a transaction before the end of 2023."
在Corbion第一季度业绩的基础上，尽管存在一些挑战性的情况，我们仍在按计划改善全年的绝对调整后EBITDA，并相应地将我们的预期增长上调至我们15-20%的指导范围的上端。此外，我们美国乳化剂业务的撤资过程进展顺利，我们预计在2023年底之前完成交易。“
Attachment
依附
- 20230425 Corbion 1Q23 press release ENG
- 20230425 Corbion 1Q23新闻稿英文版
